Anecdotally, some users report experiencing gastrointestinal issues like nausea, diarrhea, or constipation, as well as headache, fatigue, or irritation at the injection site
Implications for the GLP-1 market: More employers will get ahead of the high costs associated with rising GLP-1 use by significantly restricting or eliminating coverage for the drugs, particularly as new oral formulations broaden their appeal
Any perceived benefits would be indirect at best, and patients should not expect these medications to alleviate endometriosis symptoms such as pelvic pain, dysmenorrhea, or dyspareunia
restores skins natural ph 2 fl
Why Is It Important to Know the Color
Novo Nordisk is developing a high-dose oral form of semaglutide, but it hasnt yet been FDA-approved